PIONEERING HEALTHCARE FOR THE HUMAN RACE

Mundipharma introduces new BETADINETM Cold Defence to quickly and effectively tackle common colds New BETADINETM Cold Defence exhibits antiviral properties1,2 and found to combat symptoms and reduce...

Mundipharma introduces new BETADINETM Cold Defence to quickly and effectively tackle common colds New BETADINETM Cold Defence exhibits antiviral properties1,2 and found to combat symptoms and reduce...

Mundipharma set to provide innovative cold treatment for Adults and Children in new markets across the Middle East, Turkey and Africa region 16, January, Dubai: Mundipharma, the maker of the...

EmtrixTM, the leading treatment for patients suffering from nail fungus and nail psoriasis, will be licensed by Mundipharma from the Swedish pharmaceutical company and to be marketed as part of the...

Nasal and ear sprays and decongestants will be available to patients aged 6 months to 10 years across Middle East, Turkey and Africa. XX August, Dubai: Mundipharma’s commitment to tackling some...

A unique non-estrogen prescription therapy, Intrarosa™, has been approved by the US Food and Drug Administration (FDA) and by the European Medical Agency (EMA), for the treatment of the most...